Bruno Sepodes is a Professor of Pharmacological Sciences at the Faculty of Pharmacy of the University of Lisbon (Portugal), where he is responsible for the courses of Pharmacotherapy I and Pharmacotherapy II from the Integrated Master of Pharmaceutical Sciences, and several other courses in Pharmacology, Therapeutics, Translational and Regulatory Science. Bruno is author and co-author of several scientific publications in international journals and presented to national and international scientific meetings. Research interests are currently focused in non-clinical, translational and clinical research, along with the exciting developments in Regulatory Science. Besides being Senior Assessor for INFARMED (the Portuguese National Authority for Medicines and Health Products), he became a member of the European Medicines Agency’s (EMA) Committee for Orphan Medicinal Products (COMP) in 2008 and served for two mandates as Chairperson of this Committee (2012-2018). Additionally, Bruno is also member of the EMA Committee for Human Medicinal Products (CHMP) and of the Committee of Advanced Therapies (CAT). Since November 2018, Bruno Sepodes is the Vice-Chair of the Committee of Human Medicinal Products (CHMP). In 2018 he received the “EURORDIS Leadership Black Pearl Award” on Rare Diseases, attributed to an individual who has demonstrated remarkable leadership in the field of rare diseases at a European level. Bruno received 15 national and international scientific awards and was on the top 100 inspirational industry professionals of “The Medicine Maker Power List 2018”, under the category ‘Masters of Change’ for year 2018.